Ozempic maker spending more than $3m to lobby fat cats in Washington as weight-loss drugs faces regulatory decisions - Novo ...

Shares of online health platform Hims & Hers Health soared Tuesday after the company announced a partnership with Novo ...

From a fundamental standpoint, Eli Lilly presently has a market capitalization of $789 billion. Over the trailing twelve ...

WW International shares are trading higher by 79% during Tuesday's session. The company announced a new partnership with Eli ...

The strategy comes as rival Eli Lilly & Co. is working with telehealth firms to distribute lower-cost vials of its own obesity medication.

Novo Nordisk appears to be letting compounded GLP-1 bygones be bygones—at least, in one respect. | Novo Nordisk appears to be ...

Hims & Hers (HIMS) stock popped more than 20% in trading early Tuesday after Novo Nordisk (NVO) announced a partnership with ...

Novo Nordisk and a popular virtual health company are making Wegovy more accessible to millions of more Americans.

WW International (NASDAQ:WW) stock surges with a new partnership to offer Eli Lilly's (LLY) weight-loss therapy Zepbound.

Wegovy and Zepbound, the two leading weight-loss drugs, together sold less than $5 billion in 2023, according to ...

Hims & Hers stock surges after Novo Nordisk announces Wegovy will be offered through telehealth platforms as shortages ease ...